Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

May 25, 2020
Review

Treatment for Mycobacterium avium complex lung disease

Journal of the Formosan Medical Association = Taiwan Yi Zhi
Sheng-Wei PanWei-Juin Su
May 23, 2020
Open Access

Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean

Revista Panamericana De Salud Pública = Pan American Journal of Public Health
Ralfh MorenoRafael Lopez
May 28, 2020
Open Access

Identification of Substituted Amino Acid Hydrazides as Novel Anti-Tubercular Agents, Using a Scaffold Hopping Approach

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Alistair K BrownJonathan D Sellars
May 18, 2020

Evaluation of pharmacokinetic-pharmacodynamic relationships and selection of drug combinations for tuberculosis

British Journal of Clinical Pharmacology
Morris Muliaditan, Oscar Della Pasqua
May 22, 2020

Bile acids, lipid and purine metabolism involved in hepatotoxicity of first-line anti-tuberculosis drugs

Expert Opinion on Drug Metabolism & Toxicology
Linsheng LiuLiyan Miao
May 15, 2020

Novel Aminopyrazole Tagged Hydrazones as Anti-Tubercular Agents: Synthesis and Molecular Docking Studies

Medicinal Chemistry
Thatavarthi PadminiBigala Raj Kamal
May 28, 2020
Open Access

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment

Pharmaceutics
Konstantina ChachlioutakiDimitrios G Fatouros
May 21, 2020

Safety and treatment completion of latent tuberculosis infection treatment in elderly population- a prospective observational study in Taiwan

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Jia-Yih FengWei-Juin Su
May 27, 2020

Relevance of mouse lung tumors to human risk assessment

Journal of Toxicology and Environmental Health. Part B, Critical Reviews
Samuel M CohenJames S Bus
May 25, 2020

MmpL3 inhibitors as antituberculosis drugs

European Journal of Medicinal Chemistry
Min ShaoXiaoyun Lu
May 14, 2020

First-line tuberculosis treatment with double-dose rifampicin is well tolerated

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
A K J MaugA Van Deun
May 14, 2020

Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid

The European Respiratory Journal
Simone H J van den ElsenJan-Willem C Alffenaar

Sign up to follow this feed and discover related papers.

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2020 Meta ULC. All rights reserved
/feed-previews/antitubercular-agents/734da6ab-6ed9-4b0d-8c4b-3d53d507d4a8